Measuring health-related quality of life and neutropenia-specific concerns among older adults undergoing chemotherapy: validation of the Functional Assessment of Cancer Therapy–Neutropenia (FACT-N)-Reference-Cited by-同舟云学术

Measuring health-related quality of life and neutropenia-specific concerns among older adults undergoing chemotherapy: validation of the Functional Assessment of Cancer Therapy–Neutropenia (FACT-N)

Published:2007-07-10 Issue:1 Volume:16 Page:47-56
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Wagner Lynne I.,Beaumont Jennifer L.,Ding Beiying,Malin Jennifer,Peterman Amy,Calhoun Elizabeth,Cella David

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-007-0270-7.pdf

Reference20 articles.

1. Balducci L, Extermann M (2000) Management of cancer in the older person: a practical approach. Oncologist 5:224–237

2. Balducci L, Tam J, Al-Halawani H, Shahin S, Green J, Dansey R, Ershler W (2005) A large study of the older cancer patient in the community setting: initial report of a randomized controlled trial using pegfilgrastim to reduce neutropenic complications. 2005 ASCO Annual Meeting Proceedings, Part I of II. J Clin Oncol 23(16S):8111 (June 1 Supplement)

3. Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the hospital anxiety and depression scale: an updated literature review. J Psychosom Res 52:69–77

4. Brucker P, Yost K, Cashy J, Webster K, Cella D (2005) General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof 28:192–211

5. Butt Z, Webster K, Eisenstein AR, Beaumont J, Eton D, Master GA, Cella D (2005) Quality of life in lung cancer: the validity and cross-cultural applicability of the Functional assessment of cancer therapy-lung scale. Hematol/Oncol Clin North Am 19:389–420

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative cost-effectiveness analysis of CDK4/6 inhibitors in the first-line treatment of HR-positive and HER2-negative advanced breast cancer: a Markov's model-based evaluation;Frontiers in Oncology;2024-07-24

2. The impact of myelosuppression on quality of life of patients treated with chemotherapy;Future Oncology;2024-04-25

3. A pilot study of the mistletoe and breast cancer (MAB) trial: a protocol for a randomised double-blind controlled trial;Pilot and Feasibility Studies;2022-04-06

4. Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival;JNCI: Journal of the National Cancer Institute;2021-03-17

5. Side effects of using granulocyte-colony stimulating factors as prophylaxis of febrile neutropenia in cancer patients: A systematic review;Critical Reviews in Oncology/Hematology;2021-01